4//SEC Filing
Genextra S.p.A. 4
Accession 0001140361-20-018621
CIK 0001270073other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 8:13 PM ET
Size
8.8 KB
Accession
0001140361-20-018621
Insider Transaction Report
Form 4
Genextra S.p.A.
10% Owner
Transactions
- Sale
Common stock, par value $0.001 per share
2020-08-14$50.55/sh−54,600$2,760,112→ 5,362,400 total - Sale
Common stock, par value $0.001 per share
2020-08-17$50.15/sh−126,888$6,362,913→ 5,235,512 total - Sale
Common stock, par value $0.001 per share
2020-08-17$46.75/sh−1,235,512$57,760,186→ 4,000,000 total - Sale
Common stock, par value $0.001 per share
2020-08-13$52.60/sh−83,000$4,365,451→ 5,417,000 total
Footnotes (1)
- [F1]Genextra S.p.A. will apply the proceeds from the sales to pay off outstanding indebtedness under its margin loan secured by its shares of Intercept's common stock, and for general corporate purposes.
Documents
Issuer
INTERCEPT PHARMACEUTICALS, INC.
CIK 0001270073
Entity typeother
IncorporatedItaly
Related Parties
1- filerCIK 0001559515
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 8:13 PM ET
- Size
- 8.8 KB